Takeda Pharmaceutical Company (TAKN) Ownership - Who Owns Takeda Pharmaceutical Company?
Takeda Pharmaceutical Company (TAKN) Ownership Overview
- 0.12% Insiders
- 0.88% Mutual Funds
- 0.09% Other Institutional Investors
- 0.14% ETFs
- 98.77% Public Companies and Individual Investors
The ownership structure of Takeda Pharmaceutical Company (MX:TAKN) stock is a mix of institutional, retail, and individual investors. Approximately 1.11% of the company’s stock is owned by Institutional Investors, 0.12% is owned by Insiders, and 98.77% is owned by Public Companies and Individual Investors.
The ownership structure of Takeda Pharmaceutical Company (MX:TAKN) stock is a mix of institutional, retail, and individual investors. Approximately 1.11% of the company’s stock is owned by Institutional Investors, 0.12% is owned by Insiders, and 98.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 14, 2026 | Duprey Lauren Rusckowski | $640,279 | |
| Aug 18, 2026 | Greenway Nicola Deidre Petal | $235,068 | |
| Aug 11, 2026 | Shannon Elaine Mary | $357,371 | |
| Aug 11, 2026 | Greenway Nicola Deidre Petal | $605,553 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| American Mutual Fund | 18,157,900 | Institution | 0.57% | 333,342,728 |
| Capital Income Builder | 7,343,700 | Institution | 0.23% | 134,815,645 |
| Charles Brandes | 4,539,347 | Institution | 0.14% | 83,333,332 |
| BlackRock, Inc. | 3,688,166 | Institution | 0.12% | 67,707,351 |
| First Trust | 1,625,630 | Institution | 0.05% | 29,843,316 |
| Vaneck | 1,498,130 | Institution | 0.05% | 27,502,671 |
| Steward Funds Inc | 1,037,163 | Institution | 0.03% | 19,040,238 |
| Andrew Stewart Plump | 912,034 | Insider | 0.03% | 16,743,120 |
| Avantis | 596,098 | Institution | 0.02% | 10,943,167 |
| Mercer Funds | 586,098 | Institution | 0.02% | 10,759,587 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| American Mutual Fund | 18,157,900 | Institution | 0.57% | 333,342,728 |
| Capital Income Builder | 7,343,700 | Institution | 0.23% | 134,815,645 |
| Steward Funds Inc | 1,037,163 | Institution | 0.03% | 19,040,238 |
| Mercer Funds | 586,098 | Institution | 0.02% | 10,759,587 |
| Goldman Sachs Trust | 494,442 | Institution | 0.02% | 9,076,966 |
| Mutual Fund Series Trust | 272,000 | Institution | <0.01% | 4,993,376 |
| Carillon Series Trust | 160,000 | Institution | <0.01% | 2,937,280 |
| Vanguard International Equity Index Funds | 123,374 | Institution | <0.01% | 2,264,900 |
| Fidelity Rutland Square Trust Ii | 66,379 | Institution | <0.01% | 1,218,586 |
| Rbb Fund, Inc. | 45,237 | Institution | <0.01% | 830,461 |
FAQ
Who Owns Takeda Pharmaceutical Company (MX:TAKN)?
According to the latest TipRanks data, approximately 1.11% of the company's stock is held by institutional investors, 0.12% is held by insiders, and 98.77% is held by public companies and individual investors.
What percentage of Takeda Pharmaceutical Company (MX:TAKN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.11% of Takeda Pharmaceutical Company (MX:TAKN) stock is held by institutional investors: 0.88% by mutual funds, 0.14% by ETFs and 0.09% by other institutional investors.
What percentage of Takeda Pharmaceutical Company (MX:TAKN) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.77% of Takeda Pharmaceutical Company (MX:TAKN) stock is held by public companies and individual investors.
Who owns the most shares of Takeda Pharmaceutical Company (MX:TAKN)?
American Mutual Fund owns the most shares of Takeda Pharmaceutical Company (MX:TAKN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
